| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.06B | 19.63B | 15.78B | 20.28B | 33.76B | 17.64B |
| Gross Profit | 7.63B | 5.69B | 5.29B | 8.12B | 11.53B | 5.62B |
| EBITDA | 12.03B | 11.18B | 8.20B | 17.54B | 6.23B | 564.00M |
| Net Income | 1.48B | 5.33B | 3.25B | 9.88B | 1.43B | -2.34B |
Balance Sheet | ||||||
| Total Assets | 46.84B | 49.13B | 43.86B | 43.08B | 41.27B | 39.26B |
| Cash, Cash Equivalents and Short-Term Investments | 1.77B | 1.58B | 2.64B | 4.07B | 1.35B | 1.40B |
| Total Debt | 26.41B | 28.61B | 25.59B | 26.32B | 27.95B | 31.95B |
| Total Liabilities | 38.17B | 36.05B | 33.80B | 34.06B | 41.44B | 39.29B |
| Stockholders Equity | 3.75B | 7.92B | 5.70B | 5.06B | -2.97B | -2.57B |
Cash Flow | ||||||
| Free Cash Flow | 4.53B | 2.46B | 3.16B | 6.30B | 8.69B | 1.50B |
| Operating Cash Flow | 5.39B | 5.54B | 5.39B | 8.42B | 10.52B | 2.47B |
| Investing Cash Flow | -3.33B | -2.89B | -2.28B | -2.20B | -1.84B | -912.00M |
| Financing Cash Flow | -3.16B | -4.25B | -4.45B | -4.18B | -8.01B | -1.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $75.18B | 19.11 | 10.69% | 4.27% | 12.38% | 28.17% | |
73 Outperform | $69.06B | 13.25 | 13.97% | 8.04% | 12.46% | -10.48% | |
73 Outperform | $85.74B | 13.95 | 20.04% | 6.72% | -9.49% | 1.01% | |
73 Outperform | $59.24B | 18.41 | 15.92% | 5.61% | 41.04% | 9.18% | |
70 Outperform | $50.47B | -4.26 | 23.48% | 1.07% | 24.15% | -55.07% | |
70 Outperform | $95.97B | 24.40 | 22.37% | 3.35% | 9.99% | 22.02% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |